

Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1360, 2002-01, pp. : 17-17
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Structured treatment interruption strategy effective for HIV infection
Inpharma, Vol. 1, Iss. 1560, 2006-01 ,pp. :


Nevirapine not recommended for prophylaxis of HIV-1 infection
Inpharma, Vol. 1, Iss. 1301, 2001-01 ,pp. :


Therapy interruption in HIV infection an option?
Inpharma, Vol. 1, Iss. 1236, 2000-01 ,pp. :


Inpharma, Vol. 1, Iss. 1259, 2000-01 ,pp. :


Nevirapine unsafe for HIV-1 infection prophylaxis?
Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. :